Biotech

All Articles

Boehringer offers up to $1.3 B for gate prevention biotech

.Boehringer Ingelheim is actually providing to $1.3 billion for Nerio Rehabs and a preclinical invul...

Ventyx's last resort for inflamed med ends in Crohn's failure

.Ventyx Biosciences' Crohn's disease medication did certainly not help patients attain remission in ...

Cognition's period 2 sparkle information tarnish Alzheimer's prospect

.Cognition Therapies' period 2 luster trial has actually taken a number of the radiance off the Alzh...

BMS centers bispecific months after filing to function phase 3 trial

.Bristol Myers Squibb has actually had a whiplash change of heart on its own BCMA bispecific T-cell ...

Charles Baum takes control of Terremoto as chief executive officer

.Charles Baum, M.D., Ph.D., who looked after Mirati Therapies' $ 5.8 billion sale to Bristol Myers S...

Asarina to close after attempts to partner Tourette's medication fail

.After reaching out to much more than 200 providers to partner a Tourette syndrome therapy that reve...

Novartis markers $150M upfront bispecifics take care of Dren Biography

.Novartis has actually possessed some rotten luck with bispecific antibodies previously, but judging...

AstraZeneca vegetations an EGFR tree along with Pinetree package worth $45M

.Pinetree Therapeutics will help AstraZeneca plant some plants in its own pipe with a brand-new cont...

GRO rounds up $60M series B to take gout treatment into center

.GRO Biosciences has ended the week along with an extra $60.3 thousand in the bank, which the health...

Chutes &amp Ladders-- Gilead's Merdad Parsey goes, Cassava loses chief executive officer

.Invite to this week's Chutes &amp Ladders, our summary of considerable leadership hirings, shooting...